Actin-binding protein Anillin promotes the progression of gastric cancer in vitro and in mice.
BACKGROUND
To detect the expression levels of actin-binding protein anillin (ANLN) in human gastric cancer (GC) tissues and explore the possible involvement of ANLN in GC cell proliferation, migration, and invasion.


METHODS
The bioinformation analysis was performed in TCGA database to explore the expression of ANLN in human GC tissues and the difference of ANLN expression between multiple types of cancers. IHC assays and clinical pathological analysis were performed to confirm ANLN expression and its correlation with clinical features of GC patients. Colony formation, CCK-8, wound closure, and transwell assays were performed to detect its effects on GC cell proliferation, migration, and invasion in vitro. Tumor growth was also measured using a xenograft animal model.


RESULTS
We found the high expression of ANLN in human GC tissues based on the results from TCGA database and IHC staining. We further noticed ANLN depletion resulted in the inhibition of GC cell proliferation, migration, and invasion. Our data further confirmed that ANLN contributed to tumor growth of GC cells in vivo.


CONCLUSIONS
We confirmed the involvement of ANLN in GC progression and thought ANLN could serve as a promising therapeutic target for GC.
['Jia|Huanxia|H|', 'Yu|Fang|F|', 'Li|Baoyu|B|', 'Gao|Zhenya|Z|https://orcid.org/0000-0003-0134-9944']
D000818:Animals D045744:Cell Line, Tumor D002465:Cell Movement D049109:Cell Proliferation D005260:Female D006801:Humans D008297:Male D008819:Mice, Nude D008840:Microfilament Proteins D008875:Middle Aged D013274:Stomach Neoplasms D023041:Xenograft Model Antitumor Assays
anillin (ANLN) gastric cancer (GC) proliferation migration invasion